DMAP1 Deficiency Suppresses Lung Cancer Progression by Destabilizing Replication Fork and Activating IFN...

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Lung cancer is a leading cause of mortality despite advances in treatment.
• Novel therapeutic strategies are urgently needed to combat lung cancer.
• DNA methyltransferase 1-associated protein 1 (DMAP1) role in lung cancer is not well understood.

Purpose of the Study:

• To identify novel regulators of lung cancer progression.
• To investigate the function of DMAP1 in lung cancer.
• To explore DMAP1 as a potential therapeutic target.

Main Methods:

• CRISPR-based knock-out screen to identify key regulators.
• Functional studies on DMAP1-deficient lung cancer cells.
• Analysis of DNA damage, genome stability, and immune response.
• Clinical data analysis of DMAP1 expression and patient survival.

Main Results:

• DMAP1 was identified as a critical regulator of lung cancer progression.
• DMAP1 deficiency suppressed tumor cell proliferation and enhanced T cell-mediated anti-tumor immunity.
• DMAP1 loss induced DNA damage and activated IFN signaling, promoting anti-tumor immune response.
• High DMAP1 expression correlated with a "cold" tumor microenvironment and reduced overall survival.

Conclusions:

• DMAP1 plays a significant role in lung cancer development and progression.
• Targeting DMAP1 may represent a novel therapeutic strategy for lung cancer.
• DMAP1 modulation can impact both tumor cell growth and anti-tumor immunity.